Citations

Mayo Clinic

Showing 10 of 108585 citations.

Integrating Lifestyle Factor Science into Neuropsychological Practice: A National Academy of Neuropsychology Education Paper
Randolph, John J. , Lacritz, Laura H. , Colvin, Mary K. , Espe‐Pfeifer, Patricia , Carter, Kirstine R, Arnett, Peter A. , Fox‐Fuller, Joshua T. , Aduen, Paula, Sperling, Scott A. , Aduen, Paula A., Espe-Pfeifer, Patricia , Sperling, Scott , Cullum, C. Munro

Archives of Clinical Neuropsychology | October 24, 2023 | Volume: 39 | Issue: 2 | Pages: 121-139

10.1093/arclin/acad078 | PMID 37873931 Get It

Abstract Objective The primary aim of this paper is to review evidence and clinical implications related to lifestyle activities associated with promoting brain and cognitive health. Our review targets four key lifestyle factors: physical activity and exercise, social engagement, cognitively stimulating activity, and consuming Mediterranean-style diets. Method We conducted a critical review of the lifestyle factor literature in the four domains listed earlier. We contextualize this literature review by translating findings, when possible, into evidence-based recommendations to consider when providing neuropsychological services. Results There is significant current evidence supporting the role of physical activity and exercise, social engagement, cognitively stimulating activity, and consuming Mediterranean-style diets on positive brain and cognitive health outcomes. While some null findings are present in all four areas reviewed, the weight of the evidence supports the notion that engaging in these activities may promote brain and cognitive functioning. Conclusions Clinical neuropsychologists can have confidence in recommending engagement in physical activity, social activity, and cognitively stimulating activity, and adhering to a Mediterranean-style diet to promote brain and cognitive health. We discuss limitations in existing lifestyle factor research and future directions to enhance the existing evidence base, including additional research with historically underrepresented groups and individuals with neurological conditions.
Mendelian randomization in hepatology: A review of principles, opportunities, and challenges
Song, Yilin , Ye, Ting , Roberts, Lewis R. , Larson, Nicholas B. , Winham, Stacey J. , Roberts, Lewis R , Winham, Stacey J , Larson, Nicholas B

Hepatology | October 24, 2023 | Volume: 81 | Issue: 6 | Pages: 1836-1846

10.1097/hep.0000000000000649 | PMID 37874245 Get It

Mendelian randomization has become a popular tool to assess causal relationships using existing observational data. While randomized controlled trials are considered the gold standard for establishing causality between exposures and outcomes, it is not always feasible to conduct a trial. Mendelian randomization is a causal inference method that uses observational data to infer causal relationships by using genetic variation as a surrogate for the exposure of interest. Publications using the approach have increased dramatically in recent years, including in the field of hepatology. In this concise review, we describe the concepts, assumptions, and interpretation of Mendelian randomization as related to studies in hepatology. We focus on the strengths and weaknesses of the approach for a non-statistical audience, using an illustrative example to assess the causal relationship between body mass index and NAFLD.
Lower Cranial Nerve Schwannomas: Cohort Study and Systematic Review
Carlstrom, Lucas P. , Oushy, Soliman , Perry, Avital , Brown, Paul D. , Peris‐Celda, Maria , Graffeo, Christopher S. , Link, Michael J., Oushy, Soliman H , Bauman, Megan M. J. , Gompel, Jamie J. Van , Link, Michael J.

Neurosurgery | October 24, 2023 | Volume: 94 | Issue: 4 | Pages: 745-755

10.1227/neu.0000000000002735 | PMID 37874134 Get It

BACKGROUND AND OBJECTIVES: Schwannomas originating from the lower cranial nerves (LCNS) are rare and pose a significant surgical challenge. Resection is the mainstay treatment; however, risk of treatment morbidity is considerable, and the available literature regarding differential treatment outcomes in this vulnerable population is sparse. METHODS: A single-institution cohort study and systematic literature review of LCNS were performed. RESULTS: Fifty-eight patients were included: 34 underwent surgical resection and 24 underwent stereotactic radiosurgery (SRS). The median age at diagnosis was 48 years (range 17-74). Presenting symptoms were dysphagia (63%), dysarthria/hypophonia (47%), imbalance (33%), and hearing loss/tinnitus (30%). Tumor size was associated with surgical resection, as compared with initial SRS (4.1 cm vs 1.5 cm, P = .0001). Gross total resection was obtained in 52%, with tumor remnants predominantly localized to the jugular foramen (62%). Post-treatment worsening of symptoms occurred in 68% of surgical and 29% of SRS patients ( P = .003). Postoperative symptoms were mostly commonly hypophonia/hoarseness (63%) and dysphagia (59%). Seven patients (29%) had new neurological issues after SRS treatment, but symptoms were overall milder. The median follow-up was 60 months (range 12-252); 98% demonstrated meaningful clinical improvement. Eighteen surgical patients (53%) underwent adjuvant radiation at a median of 5 months after resection (range 2-32). At follow-up, tumor control was 97% in the surgical cohort and 96% among SRS patients. CONCLUSION: Although LCNS resection is potentially morbid, most postoperative deficits are transient, and patients achieve excellent tumor control—particularly when paired with adjuvant SRS. For minimally symptomatic patients undergoing surgical intervention, we advise maximally safe resection with intracapsular dissection to preserve nerve integrity where possible. For residual or as a primary treatment modality, SRS is associated with low morbidity and high rates of long-term tumor control.
Hypermobility spectrum disorders and migraine in adolescents
Chiang, Chia‐Chun , Chiang, Chia-Chun

Headache: The Journal of Head and Face Pain | October 24, 2023 | Volume: 63 | Issue: 10 | Pages: 1339-1340

10.1111/head.14650 | PMID 37873975 Get It

Robotic‐assisted parastomal hernia repair using the Sugarbaker technique
Lara, Francisco J. Cardenas , Cardenas Lara, Francisco J, Cima, Robert R.

Colorectal Disease | October 24, 2023 | Volume: 25 | Issue: 12 | Pages: 2460-2461

10.1111/codi.16779 | PMID 37872877 Get It

Prompting Rigor in Database Reporting: Working Toward Higher-Quality Plastic Surgery Database Research
Xu, Hong Hao , Davison, Peter, Winocour, Sebastian, Reece, Edward M., Vorstenbosch, Joshua , Abi‐Rafeh, Jad

Plastic & Reconstructive Surgery | October 24, 2023 | Volume: 153 | Issue: 5 | Pages: 1049e-1049e

10.1097/prs.0000000000011157 | PMID 37872667 Get It

Patent Foramen Ovale–Related Hypoxemia After Bilateral Lung Transplant
Raavi, Lekhya , Garg, Pankaj , Alomari, Mohammad , Ali, Mostafa, Wadiwala, Ishaq , Ahmed, Magdy M. El‐Sayed , Garg, Pankaj

Texas Heart Institute Journal | October 24, 2023 | Volume: 50 | Issue: 5 | Pages: No page available

10.14503/thij-23-8229 | PMID 37872694 Get It

Abstract A 64-year-old man with interstitial pulmonary fibrosis and a small patent foramen ovale with right-to-left shunting underwent bilateral lung transplant without closure of the patent foramen ovale. Postoperatively, the patient remained persistently hypoxemic with partial response to high-flow oxygen. Investigations revealed the presence of a large patent foramen ovale with right-to-left shunting on echocardiography and a shunt fraction of 21% on cardiac catheterization. Two months after the lung transplantation, primary surgical repair of the patent foramen ovale was performed with immediate improvement in oxygenation. Three years postoperatively, the patient remained oxygen independent.
Cell Therapy Improves Quality-of-Life in Heart Failure: Outcomes From a Phase III Clinical Trial
Yamada, Satsuki , Bartúnek, Jozef , Povsic, Thomas J. , Davison, Beth A. , Edwards, Christopher , Behfar, Atta , Metra, Marco , Filippatos, Gerasimos , Vanderheyden, Marc , Cotter, Gad , Davison, Beth A , Behfar, Atta , Metra, Marco , Filippatos, Gerasimos S , Vanderheyden, Marc , Wijns, William , Terzic, Andre , Bartunek, Jozef , Wijns, William , Terzic, André

Stem Cells Translational Medicine | October 24, 2023 | Volume: 13 | Issue: 2 | Pages: 116-124

10.1093/stcltm/szad078 | PMID 38006196 Get It

Abstract Patients with heart failure experience limitations in daily activity and poor quality-of-life. Prospective surveillance of health-related quality-of-life supplemented traditional death and hospitalization outcomes in the multinational, randomized, double-blinded CHART-1 clinical trial that assessed cardiopoiesis-guided cell therapy in ischemic heart failure patients with reduced left ventricular ejection fraction. The Minnesota Living with Heart Failure Questionnaire (MLHFQ), a Food and Drug Administration qualified instrument for evaluating therapeutic effectiveness, was applied through the 1-year follow-up. Cell treated (n = 109) and sham procedure (n = 140) cohorts reported improved MLHFQ scores comparable between the 2 study arms (mean treatment difference with baseline adjustment −3.2 points, P = .107). Superiority of cell treatment over sham in betterment of the MLHFQ score was demonstrated in patients with pre-existing advanced left ventricular enlargement (baseline-adjusted mean treatment difference −6.4 points, P = .009). In this highly responsive subpopulation, benefit on the MLHFQ score paralleled reduction in death and hospitalization post-cell therapy (adjusted Mann-Whitney odds 1.43, 95% CI, 1.01-2.01; P = .039). The potential of cell therapy in addressing the quality-of-life dimension of heart failure requires further evaluation for disease relief.
Does the duration of ambulatory consultations affect the quality of healthcare? A systematic review
León‐García, Montserrat , Wieringa, Thomas H. , Hernández, María José , Villanueva, Gemma , Ospina, Naykky Singh , Hidalgo, Jessica, Calderón, Claudio Rocha, Zeballos‐Palacios, Claudia , Brito, Juan P. , Zeballos-Palacios, Claudia, Brito, Juan Pablo, Singh Ospina, Naykky , Brito, Juan P , Suárez, Nataly R. Espinoza , Prokop, Larry J. , LeBlanc, Annie , Montori, Víctor M.

BMJ Open Quality | October 24, 2023 | Volume: 12 | Issue: 4 | Pages: e002311

10.1136/bmjoq-2023-002311 | PMID 37875307 Get It

Background The objective is to examine and synthesise the best available experimental evidence about the effect of ambulatory consultation duration on quality of healthcare. Methods We included experimental studies manipulating the length of outpatient clinical encounters between adult patients and clinicians (ie, therapists, pharmacists, nurses, physicians) to determine their effect on quality of care (ie, effectiveness, efficiency, timeliness, safety, equity, patient-centredness and patient satisfaction). Information sources Using controlled vocabulary and keywords, without restriction by language or year of publication, we searched MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials and Database of Systematic Reviews and Scopus from inception until 15 May 2023. Risk of bias Cochrane Risk of Bias instrument. Data synthesis Narrative synthesis. Results 11 publications of 10 studies explored the relationship between encounter duration and quality. Most took place in the UK’s general practice over two decades ago. Study findings based on very sparse and outdated evidence—which suggested that longer consultations improved indicators of patient-centred care, education about prevention and clinical referrals; and that consultation duration was inconsistently related to patient satisfaction and clinical outcomes—warrant low confidence due to limited protections against bias and indirect applicability to current practice. Conclusion Experimental evidence for a minimal or optimal duration of an outpatient consultation is sparse and outdated. To develop evidence-based policies and practices about encounter length, randomised trials of different consultation lengths—in person and virtually, and with electronic health records—are needed. Trial registration number OSF Registration DOI:10.17605/OSF.IO/EUDK8.
Surgical Management of Swan Neck Deformity Following Mallet Finger Injury: A Review of 25 Patients Over 20 Years
Rode, Matthew M. , Mullen, Barbara , Zhu, Agnes , Helsper, Elizabeth, Moran, Steven L. , Zhu, Agnes Q, Helsper, Elizabeth A, Rode, Matthew

HAND | October 24, 2023 | Volume: 20 | Issue: 2 | Pages: 197-202

10.1177/15589447231205616 | PMID 37872782 Get It

Introduction: Swan neck deformity develops as a sequela of chronic mallet finger. Surgical management can include soft tissue reconstruction or distal interphalangeal joint (DIPJ) fusion. Studies examining the incidence and management of posttraumatic swan neck deformity following mallet fracture are limited. Methods: A retrospective, single-institution review of patients undergoing surgical management of swan neck deformity following a traumatic mallet finger from 2000 to 2021 was performed. Patients with preexisting rheumatoid arthritis were excluded. Injury, preoperative clinical, and surgical characteristics were recorded along with postoperative outcomes and complications. Results: Twenty-five patients were identified who had surgical intervention for swan neck deformity. Sixty-four percent of mallet fingers were chronic. Median time to development of mallet finger was 2 months. Twelve (48%) mallet fingers were Doyle class I, 6 (24%) were class III, and 7 (28%) were class IVB. Forty percent of injuries failed nonoperative splinting trials. Sixteen (64%) underwent primary DIPJ arthrodesis, 8 (32%) underwent DIPJ pinning, and 1 underwent open reduction and internal fixation of mallet fracture. The complication rate was 50% overall, and 33% of surgeries experienced major complications. The overall reoperation rate was 33%. Proximal interphalangeal joint hyperextension improved by 11° on average. Median follow-up was 61.2 months. Conclusions: The development of symptomatic swan neck deformity following traumatic mallet finger injury is rare. All patients warrant an attempt at nonsurgical management. Attempts at surgical correction had a high rate of complications, and DIPJ fusion appeared to provide the most reliable solution.